The discovery of GLP-1 drugs represents one of the most spectacular medical breakthroughs of the century, dramatically reshaping the landscape of treatment for obesity and related conditions.
Former Harvard Medical School dean Jeffrey Flier reflects that though nearly 40 years ago they sought to develop GLP-1 for diabetes, its vast benefits extend to weight loss and an array of diseases.
The onset of widespread GLP-1 usage in 2023 highlights not only its effectiveness in managing diabetes and obesity but also its potential to curb chronic diseases like Alzheimer's and heart disease.
Collection
[
|
...
]